• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

魁北克血小板紊乱患者的尿激酶纤溶酶原激活物基因 PLAU 存在串联重复。

Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene.

机构信息

Genetics and Genome Biology, Hospital for Sick Children, Toronto, ON, Canada.

出版信息

Blood. 2010 Feb 11;115(6):1264-6. doi: 10.1182/blood-2009-07-233965. Epub 2009 Dec 9.

DOI:10.1182/blood-2009-07-233965
PMID:20007542
Abstract

Quebec platelet disorder (QPD) is an autosomal dominant bleeding disorder linked to a region on chromosome 10 that includes PLAU, the urokinase plasminogen activator gene. QPD increases urokinase plasminogen activator mRNA levels, particularly during megakaryocyte differentiation, without altering expression of flanking genes. Because PLAU sequence changes were excluded as the cause of this bleeding disorder, we investigated whether the QPD mutation involved PLAU copy number variation. All 38 subjects with QPD had a direct tandem duplication of a 78-kb genomic segment that includes PLAU. This mutation was specific to QPD as it was not present in any unaffected family members (n = 114), unrelated French Canadians (n = 221), or other persons tested (n = 90). This new information on the genetic mutation will facilitate diagnostic testing for QPD and studies of its pathogenesis and prevalence. QPD is the first bleeding disorder to be associated with a gene duplication event and a PLAU mutation.

摘要

魁北克血小板功能紊乱症(QPD)是一种常染色体显性出血性疾病,与包括尿激酶纤溶酶原激活物基因(PLAU)在内的 10 号染色体区域相关。QPD 增加了尿激酶纤溶酶原激活物 mRNA 水平,尤其是在巨核细胞分化过程中,但不改变侧翼基因的表达。由于排除了 PLAU 序列改变是导致这种出血性疾病的原因,我们研究了 QPD 突变是否涉及 PLAU 拷贝数变异。所有 38 名 QPD 患者均存在 PLAU 在内的 78kb 基因组片段的直接串联重复。该突变是 QPD 所特有的,因为它不存在于任何未受影响的家族成员(n=114)、无关的法国裔加拿大人(n=221)或其他受检者(n=90)中。关于这种基因突变的新信息将有助于 QPD 的诊断检测,以及其发病机制和流行率的研究。QPD 是首个与基因重复事件和 PLAU 突变相关的出血性疾病。

相似文献

1
Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene.魁北克血小板紊乱患者的尿激酶纤溶酶原激活物基因 PLAU 存在串联重复。
Blood. 2010 Feb 11;115(6):1264-6. doi: 10.1182/blood-2009-07-233965. Epub 2009 Dec 9.
2
Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes.魁北克血小板紊乱与尿激酶型纤溶酶原激活剂基因(PLAU)相关,并增加巨核细胞中相关等位基因的表达。
Blood. 2009 Feb 12;113(7):1543-6. doi: 10.1182/blood-2008-08-175216. Epub 2008 Nov 6.
3
The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes.魁北克血小板紊乱的重复突变会使PLAU失调,但不会使C10orf55失调,从而选择性地增加巨核细胞而非粒细胞产生正常PLAU转录本的量。
PLoS One. 2017 Mar 16;12(3):e0173991. doi: 10.1371/journal.pone.0173991. eCollection 2017.
4
Quebec platelet disorder.魁北克血小板疾病。
Expert Rev Hematol. 2011 Apr;4(2):137-41. doi: 10.1586/ehm.11.5.
5
Enhancer-gene rewiring in the pathogenesis of Quebec platelet disorder.魁北克血小板紊乱发病机制中的增强子-基因重排。
Blood. 2020 Dec 3;136(23):2679-2690. doi: 10.1182/blood.2020005394.
6
Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment.魁北克血小板疾病:发病机制、诊断和治疗的最新进展。
Semin Thromb Hemost. 2011 Sep;37(6):713-20. doi: 10.1055/s-0031-1291382. Epub 2011 Nov 18.
7
Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.患有魁北克血小板紊乱症的患者的血小板含有并分泌异常量的尿激酶型纤溶酶原激活剂。
Blood. 2001 Jul 15;98(2):257-65. doi: 10.1182/blood.v98.2.257.
8
Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.魁北克血小板疾病中尿激酶型纤溶酶原激活剂表达增加与巨核细胞分化有关。
Blood. 2009 Feb 12;113(7):1535-42. doi: 10.1182/blood-2008-08-172338. Epub 2008 Nov 24.
9
Quebec platelet disorder: features, pathogenesis and treatment.魁北克血小板疾病:特征、发病机制与治疗
Blood Coagul Fibrinolysis. 2008 Mar;19(2):109-19. doi: 10.1097/MBC.0b013e3282f41e3e.
10
Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder.魁北克血小板疾病中纤维蛋白溶解级联反应的细胞内激活。
Thromb Haemost. 2003 Aug;90(2):293-8. doi: 10.1160/TH02-12-0323.

引用本文的文献

1
Cerebral sinus venous thrombosis in a child with Québec platelet disorder with high-resolution intracellular localization of urokinase in platelets.患有魁北克血小板疾病的儿童发生脑静脉窦血栓形成,尿激酶在血小板中的高分辨率细胞内定位。
Res Pract Thromb Haemost. 2025 Jul 5;9(5):102966. doi: 10.1016/j.rpth.2025.102966. eCollection 2025 Jul.
2
Protein -Fucosyltransferases: Biological Functions and Molecular Mechanisms in Mammals.蛋白质岩藻糖基转移酶:哺乳动物中的生物学功能与分子机制
Molecules. 2025 Mar 26;30(7):1470. doi: 10.3390/molecules30071470.
3
Molecular characterization of positively selected genes contributing aquatic adaptation in marine mammals.
海洋哺乳动物水生适应中受正选择影响基因的分子特征。
Genes Genomics. 2024 Jul;46(7):775-783. doi: 10.1007/s13258-023-01487-2. Epub 2024 May 11.
4
Evaluating the clinical validity of genes related to hemostasis and thrombosis using the Clinical Genome Resource gene curation framework.使用临床基因组资源基因注释框架评估与止血和血栓形成相关基因的临床有效性。
J Thromb Haemost. 2024 Mar;22(3):645-665. doi: 10.1016/j.jtha.2023.11.011. Epub 2023 Nov 26.
5
Whole genome sequencing identifies structural variants contributing to hematologic traits in the NHLBI TOPMed program.全基因组测序鉴定出导致 NHLBI TOPMed 计划中血液学特征的结构变异。
Nat Commun. 2022 Dec 8;13(1):7592. doi: 10.1038/s41467-022-35354-7.
6
Identification of de novo EP300 and PLAU variants in a patient with Rubinstein-Taybi syndrome-related arterial vasculopathy and skeletal anomaly.在一位伴有动脉血管病变和骨骼异常的 Rubinstein-Taybi 综合征相关患者中鉴定出 EP300 和 PLAU 的新生变异。
Sci Rep. 2021 Aug 5;11(1):15931. doi: 10.1038/s41598-021-95133-0.
7
Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts.在针对魁北克血小板疾病的长期氨甲环酸治疗期间血小板计数得到改善,这表明潜在的纤维蛋白溶解缺陷是血小板计数降低的原因。
Int J Lab Hematol. 2020 Dec;42(6):e274-e276. doi: 10.1111/ijlh.13311. Epub 2020 Aug 9.
8
Thrombin generation abnormalities in Quebec platelet disorder.魁北克血小板疾病中的凝血酶生成异常。
Int J Lab Hematol. 2020 Dec;42(6):801-809. doi: 10.1111/ijlh.13302. Epub 2020 Aug 6.
9
Enhancer-gene rewiring in the pathogenesis of Quebec platelet disorder.魁北克血小板紊乱发病机制中的增强子-基因重排。
Blood. 2020 Dec 3;136(23):2679-2690. doi: 10.1182/blood.2020005394.
10
Genetic classification and confirmation of inherited platelet disorders: current status in Korea.遗传性血小板疾病的基因分类与确诊:韩国的现状
Clin Exp Pediatr. 2020 Mar;63(3):79-87. doi: 10.3345/kjp.2019.00052. Epub 2020 Feb 6.